Aurora Cannabis Inc. [ACB] moved up 1.27: Why It’s Important

Related

Aurora Cannabis Inc. [NASDAQ: ACB] surged by $0.02 during the normal trading session on Friday and reaching a high of $1.64 during the day while it closed the day at $1.60. The company report on June 3, 2022 that Aurora Cannabis Repurchases US$20 Million of Convertible Notes.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Aurora Further Strengthens Balance Sheet with Accretive Debt Reduction .

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that it has repurchased an aggregate of approximately $25.3 million (US$20 million) principal amount of its convertible senior notes (“Notes”) at a total cost, including accrued interest, of $24.3 million (US$19.2 million) in cash.

Aurora Cannabis Inc. stock has also loss -41.39% of its value over the past 7 days. However, ACB stock has declined by -52.10% in the 3 months of the year. Over the past six months meanwhile, it has lost -73.94% and lost -70.43% year-on date.

The market cap for ACB stock reached $443.70 million, with 214.66 million shares outstanding and 214.63 million shares in the current float. Compared to the average trading volume of 9.90M shares, ACB reached a trading volume of 15594458 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Aurora Cannabis Inc. [ACB]:

MKM Partners have made an estimate for Aurora Cannabis Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on September 28, 2021. While these analysts kept the previous recommendation, Jefferies dropped their target price from $7.49 to $6.78. The new note on the price target was released on September 03, 2021, representing the official price target for Aurora Cannabis Inc. stock.

The Average True Range (ATR) for Aurora Cannabis Inc. is set at 0.27, with the Price to Sales ratio for ACB stock in the period of the last 12 months amounting to 1.97. The Price to Book ratio for the last quarter was 0.31, with the Price to Cash per share for the same quarter was set at 1.56.

ACB stock trade performance evaluation

Aurora Cannabis Inc. [ACB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -41.39. With this latest performance, ACB shares dropped by -49.84% in over the last four-week period, additionally sinking by -73.94% over the last 6 months – not to mention a drop of -82.53% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ACB stock in for the last two-week period is set at 28.39, with the RSI for the last a single of trading hit 24.00, and the three-weeks RSI is set at 31.45 for Aurora Cannabis Inc. [ACB]. The present Moving Average for the last 50 days of trading for this stock 3.0954, while it was recorded at 1.6180 for the last single week of trading, and 5.1294 for the last 200 days.

Aurora Cannabis Inc. [ACB]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Aurora Cannabis Inc. [ACB] shares currently have an operating margin of -157.48 and a Gross Margin at -73.36. Aurora Cannabis Inc.’s Net Margin is presently recorded at -282.16.

Return on Total Capital for ACB is now -15.16, given the latest momentum, and Return on Invested Capital for the company is -28.10. Return on Equity for this stock declined to -33.04, with Return on Assets sitting at -24.46. When it comes to the capital structure of this company, Aurora Cannabis Inc. [ACB] has a Total Debt to Total Equity ratio set at 19.61. Additionally, ACB Total Debt to Total Capital is recorded at 16.39, with Total Debt to Total Assets ending up at 14.66. Long-Term Debt to Equity for the company is recorded at 17.60, with the Long-Term Debt to Total Capital now at 14.71.

Reflecting on the efficiency of the workforce at the company, Aurora Cannabis Inc. [ACB] managed to generate an average of -$392,966 per employee. Receivables Turnover for the company is 4.44 with a Total Asset Turnover recorded at a value of 0.09.Aurora Cannabis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 5.90.

Aurora Cannabis Inc. [ACB]: Insider Ownership positions

There are presently around $61 million, or 18.28% of ACB stock, in the hands of institutional investors. The top three institutional holders of ACB stocks are: ETF MANAGERS GROUP, LLC with ownership of 9,929,796, which is approximately -13.17% of the company’s market cap and around 0.04% of the total institutional ownership; VANGUARD GROUP INC, holding 6,346,189 shares of the stock with an approximate value of $10.15 million in ACB stocks shares; and MIRAE ASSET GLOBAL INVESTMENTS CO., LTD., currently with $5.17 million in ACB stock with ownership of nearly 105.392% of the company’s market capitalization.

99 institutional holders increased their position in Aurora Cannabis Inc. [NASDAQ:ACB] by around 9,997,561 shares. Additionally, 91 investors decreased positions by around 6,767,857 shares, while 121 investors held positions by with 21,362,461 shares. The mentioned changes placed institutional holdings at 38,127,879 shares, according to the latest SEC report filing. ACB stock had 31 new institutional investments in for a total of 811,479 shares, while 50 institutional investors sold positions of 1,899,748 shares during the same period.

[class^="wpforms-"]
[class^="wpforms-"]